Sites Around the World

Vienna, Austria, is a cornerstone within the company’s global R&D network, with a special focus on cancer research. On top of that, it is also a hub for biopharmaceutical development and production.

The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany. It is the largest site, producing all new active ingredients and medications during the market launch.

The largest research and development center of Boehringer Ingelheim is located in Biberach, Germany. This site is also the largest site in Europe for biopharmaceutical manufacturing.

Ridgefield is home to the company’s US headquarters. The site serves as a key research center for human pharmaceuticals.

In the field of Animal Health, the Lyon region in France stands out as a global hub for research, development, production and supply of veterinary products.

Shanghai, China, serves as an important hub within the global network of all three business areas – Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.

The Kobe Pharma Research Institute in Kobe, Japan, takes part in the global research and development activities for human pharmaceuticals.

The Boehringer Ingelheim microParts GmbH in Dortmund, Germany, manufactures and advances the technology of the RESPIMAT®.

The site in Sant Cugat del Vallès, Spain, focuses on pharmaceutical production. It is also responsible for the manufacture of aseptic cartridges and the packaging of the RESPIMAT® product line.

With its production facilities, Fornovo San Giovanni, Italy, constitutes an important site for the production of core active pharmaceutical ingredients for both Human Pharma and Animal Health.

The site in Xochimilco, Mexico, focuses on pharmaceutical production for both Human Pharma and Animal Health.

For more than 45 years, the company has been producing pharmaceuticals in its production facility in Koropi, Greece.